Aoxing Pharmaceutical Co Inc (AOXG)
0.0072
0.00 (0.00%)
USD |
OTCM |
May 10, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 0.5487M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 620.0% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | -- |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 100.00% |
Profile
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China. |
URL | http://www.aoxingpharma.com |
Investor Relations URL | N/A |
HQ State/Province | North Carolina |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | May. 15, 2018 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China. |
URL | http://www.aoxingpharma.com |
Investor Relations URL | N/A |
HQ State/Province | North Carolina |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | May. 15, 2018 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |